Ide Smets

12PUBLICATIONS
26CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyEpidemiological modellingRadiation therapyMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 07, 2026
Individual Variability of CD19+ B-Cell Repopulation in People With Multiple Sclerosis Treated With Extended Interval Dosing of Ocrelizumab.

|Feb 16, 2026
Integrin β1 Demarks Precursors of Brain-Residing Antibody-Secreting Cells in Multiple Sclerosis.

Kirsten L Kuiper, Laurens Bogers, Jasper Rip

|Sep 23, 2025
Aggressive treatment of early acute focal inflammatory activity to extend the window for BTK inhibition in multiple sclerosis.

Joost Smolders, Ide Smets, Beatrijs Wokke

|Jun 11, 2024
Benefits of early highly effective versus escalation treatment strategies in relapsing multiple sclerosis estimated using a treatment-sequence model.

Ide Smets, Matthijs Versteegh, Simone Huygens

|Aug 02, 2023
Health-economic benefits of anti-CD20 treatments in relapsing multiple sclerosis estimated using a treatment-sequence model.

Ide Smets, Matthijs Versteegh, Simone Huygens

|May 22, 2023
Presymptomatic MS or radiologically isolated syndrome (RIS) should be actively monitored and treated - NO.

Ide Smets

Pageof 2

Frequent Collaborators

5 joint publications

Joost Smolders

5 joint publications

Beatrijs Wokke

2 joint publications

Bénédicte Dubois

1 joint publications

G Meyfroidt